Cargando…
Modification of Source Strength in Low-Dose-Rate Lung Brachytherapy with (125)I and (103)Pd Seeds
BACKGROUND: A new treatment approach for most patients who have undergone early stage non-small-cell lung carcinoma (NSCLC) is wedge resection plus permanent implant brachytherapy. However, the specification of dose to medium at low energies especially in heterogeneous lung is unclear yet. OBJECTIVE...
Autores principales: | Rezaei, H., Mostaghimi, H., Mehdizadeh, A.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Biomedical Physics and Engineering
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654126/ https://www.ncbi.nlm.nih.gov/pubmed/29082211 |
Ejemplares similares
-
New National Air-Kerma-Strength Standards for (125)I and (103)Pd Brachytherapy Seeds
por: Seltzer, Stephen M., et al.
Publicado: (2003) -
Erratum: New National Air-Kerma-Strength Standards for (125)I and (103)Pd Brachytherapy Seeds
por: Seltzer, Stephen M., et al.
Publicado: (2004) -
Reducing seed waste and increasing value of dynamic intraoperative implantation of Pd‐103 seeds in prostate brachytherapy
por: Taylor, Peter K., et al.
Publicado: (2018) -
Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy
por: Maheshwari, Abhilasha, et al.
Publicado: (2018) -
(103)Pd versus (125)I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomas
por: Finger, Paul T., et al.
Publicado: (2014)